SEARCH

SEARCH BY CITATION

References

  • Azad S. C., Eder M., Marsicano G., Lutz B., Zieglgänsberger W. and Rammes G. (2003) Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn. Mem. 10, 116128.
  • Bachy I. and Rétaux S. (2006) GABAergic specification in the basal forebrain is controlled by the LIM-hd factor Lhx7. Dev. Biol. 291, 218226.
  • Bash R., Rubovitch V., Gafni M. and Sarne Y. (2003) The stimulatory effect of cannabinoids on calcium uptake is mediated by Gs GTP-binding proteins and cAMP formation. Neurosignals 12, 3944.
  • Bellocchio L., Lafenêtre P., Cannich A., Cota D., Puente N., Grandes P., Chaouloff F., Piazza P. V. and Marsicano G. (2010) Bimodal control of stimulated food intake by the endocannabinoid system. Nat. Neurosci. 13, 281283.
  • Bosier B., Muccioli G. G., Hermans E. and Lambert D. M. (2010) Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem. Pharmacol. 80, 112.
  • Breivogel C. S., Sim L. J. and Childers S. R. (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther. 282, 16321642.
  • Chaperon F. and Thiébot M. H. (1999) Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13, 243281.
  • Demuth D. G. and Molleman A. (2006) Cannabinoid signalling. Life Sci. 78, 549563.
  • Dubreucq S., Matias I., Cardinal P., Häring M., Lutz B., Marsicano G. and Chaouloff F. (2012) Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. Neuropsychopharmacology 37, 18851900.
  • Egertová M. and Elphick M. R. (2000) Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 422, 159171.
  • Glass M. and Felder C. C. (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17, 53275333.
  • Goebbels S., Bormuth I., Bode U., Hermanson O., Schwab M. H. and Nave K.-A. (2006) Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis 44, 611621.
  • Hampson R. E., Mu J. and Deadwyler S. A. (2000) Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons. J. Neurophysiol. 84, 23562364.
  • Häring M., Marsicano G., Lutz B. and Monory K. (2007) Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 146, 12121219.
  • Häring M., Kaiser N., Monory K. and Lutz B. (2011) Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration. PLoS ONE 6, e26617.
  • Hermann H., Marsicano G. and Lutz B. (2002) Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109, 451460.
  • Howlett A. C. and Fleming R. M. (1984) Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26, 532538.
  • Jacob W., Yassouridis A., Marsicano G., Monory K., Lutz B. and Wotjak C. T. (2009) Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav. 8, 685698.
  • Kamprath K., Plendl W., Marsicano G., Deussing J. M., Wurst W., Lutz B. and Wotjak C. T. (2009) Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes Brain Behav. 8, 203211.
  • Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M. and Watanabe M. (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309380.
  • Katona I., Sperlágh B., Sík A., Käfalvi A., Vizi E. S., Mackie K. and Freund T. F. (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19, 45444558.
  • Katona I., Rancz E. A., Acsady L., Ledent C., Mackie K., Hajos N. and Freund T. F. (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21, 95069518.
  • Katona I., Urbán G. M., Wallace M., Ledent C., Jung K.-M., Piomelli D., Mackie K. and Freund T. F. (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26, 56285637.
  • Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T. and Kano M. (2006) The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 26, 29913001.
  • Kleppisch T., Wolfsgruber W., Feil S., Allmann R., Wotjak C. T., Goebbels S., Nave K.-A., Hofmann F. and Feil R. (2003) Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory. J. Neurosci. 23, 60056012.
  • Lafenêtre P., Chaouloff F. and Marsicano G. (2009) Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system. Neuropharmacology 57, 715721.
  • Lauckner J. E., Hille B. and Mackie K. (2005) The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Natl Acad. Sci. USA 102, 1914419149.
  • Marinelli S., Pacioni S., Cannich A., Marsicano G. and Bacci A. (2009) Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat. Neurosci. 12, 14881490.
  • Marsicano G. and Kuner R. (2008) Anatomical distribution of receptors, ligands and enzymes in the brain and in the spinal cord: circuitries and neurochemistry in Cannabinoids and the brain, (Kofalvi A., ed.), pp. 161201. Springer, New York.
  • Marsicano G. and Lutz B. (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11, 42134225.
  • Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S. C., Cascio M. G., Gutiérrez S. O., van der Stelt M., et al. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 8488.
  • Massa F., Mancini G., Schmidt H., Steindel F., Mackie K., Angioni C., Oliet S. H. R., Geisslinger G. and Lutz B. (2010) Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. J. Neurosci. 30, 62736281.
  • Maudsley S., Martin B. and Luttrell L. M. (2005) The origins of diversity and specificity in g protein-coupled receptor signaling. J. Pharmacol. Exp. Ther. 314, 485494.
  • McIntosh B. T., Hudson B., Yegorova S., Jollimore C. A. B. and Kelly M. E. M. (2007) Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells. Br. J. Pharmacol. 152, 11111120.
  • Metna-Laurent M., Soria-Gómez E., Verrier D., Conforzi M., Jégo P., Lafenêtre P. and Marsicano G. (2012) Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors. J. Neurosci. 32, 71097118.
  • Milligan G. (2003) Principles: extending the utility of [35S]GTP gamma S binding assays. Trends Pharmacol. Sci. 24, 8790.
  • Monory K., Massa F., Egertová M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., et al. (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455466.
  • Monory K., Blaudzun H., Massa F., Kaiser N., Lemberger T., Schütz G., Wotjak C. T., Lutz B. and Marsicano G. (2007) Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol. 5, e269.
  • Mulder J., Aguado T., Keimpema E., Barabás K., Ballester Rosado C. J., Nguyen L., Monory K., Marsicano G. and Di Marzo V. (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc. Natl Acad. Sci. USA 105, 87608765.
  • Nelson C. P. and Challiss R. A. J. (2007) ‘Phenotypic’ pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem. Pharmacol. 73, 737751.
  • Nyíri G., Szabadits E., Cserép C., Mackie K., Shigemoto R. and Freund T. F. (2005) GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons. Eur. J. Neurosci. 21, 30343042.
  • Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A. and Kano M. (2002) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci. 22, 38643872.
  • Panlilio L. V., Ferré S., Yasar S., Thorndike E. B., Schindler C. W. and Goldberg S. R. (2012) Combined effects of THC and caffeine on working memory in rats. Br. J. Pharmacol. 165, 25292538.
  • Peters M. F. and Scott C. W. (2009) Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J. Biomol. Screen. 14, 246255.
  • Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R. and Ozaita A. (2009) Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 11521158.
  • Rey A. A., Purrio M., Viveros M. P. and Lutz B. (2012) Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology 37, 26242634.
  • Roberto M., Cruz M., Bajo M., Siggins G. R., Parsons L. H. and Schweitzer P. (2010) The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 35, 19621972.
  • Scavone J. L., Mackie K. and Van Bockstaele E. J. (2010) Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors. Brain Res. 1312, 1831.
  • Schwab M. H., Bartholomae A., Heimrich B. et al. (2000) Neuronal basic helix-loop-helix proteins (NEX and BETA2/Neuro D) regulate terminal granule cell differentiation in the hippocampus. J. Neurosci. 20, 37143724.
  • Shepherd G. M. (1990) The Synaptic organization of the brain. Oxford University Press, New York.
  • Slanina K. A. and Schweitzer P. (2005) Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology 49, 653659.
  • Sousa V. C., Assaife-Lopes N., Ribeiro J. A., Pratt J. A., Brett R. R. and Sebastião A. M. (2011) Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory. Neuropsychopharmacology 36, 472487.
  • Steiner M. A., Marsicano G., Wotjak C. T. and Lutz B. (2008) Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 33, 11651170.
  • Stühmer T., Puelles L., Ekker M. and Rubenstein J. L. R. (2002) Expression from a Dlx gene enhancer marks adult mouse cortical GABAergic neurons. Cereb. Cortex 12, 7585.
  • Sulcova E., Mechoulam R. and Fride E. (1998) Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59, 347352.
  • Tsou K., Mackie K., Sañudo-Peña M. C. and Walker J. M. (1999) Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93, 969975.
  • Tzavara E. T., Wade M. and Nomikos G. G. (2003) Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J. Neurosci. 23, 93749384.